Skip to main content
logo
Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
15.90
-0.85 (-5.07%)
Nov 2, 2026, 4:00 PM EST - Market closed

Beta Bionics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
8641,341---
Market Cap Growth
-26.71%----
Enterprise Value
6301,120---
Last Close Price
15.9030.47---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
6.7913.38---
PB Ratio
2.154.66---
P/TBV Ratio
2.154.66---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
4.9511.18---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.020.030.100.070.32
Net Debt / Equity Ratio
-0.58-0.74-1.27-1.58-1.81
Net Debt / EBITDA Ratio
2.613.022.182.670.37
Net Debt / FCF Ratio
3.553.771.862.820.39
Asset Turnover
0.330.420.500.17-
Inventory Turnover
2.432.554.01--
Quick Ratio
8.047.735.529.543.12
Current Ratio
8.928.666.299.773.21
Return on Equity (ROE)
-23.88%-40.26%-81.35%-123.17%-
Return on Assets (ROA)
-14.96%-18.73%-21.78%-30.79%-
Return on Capital Employed (ROCE)
-22.50%-24.10%-35.20%-36.10%-242.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-11.62%-5.46%---
FCF Yield
-7.63%-4.19%---
Buyback Yield / Dilution
-44.45%-536.74%-20.01%-6.13%-
SEC Filings: 10-K · 10-Q